Schisandrin B ameliorates non‐alcoholic liver disease through anti‐inflammation activation in diabetic mice

Type 2 diabetes mellitus (T2DM) is a metabolic risk factor associated with non‐alcoholic liver disease (NAFLD). Schisandrin B (Sch B) is a promising agent for NAFLD. However, the actions of Sch B on diabetes‐associated NAFLD and the underlying mechanisms are not characterized. This study aimed to as...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Ruojia, Zhan, Yike, Zhang, Yamei, Wu, Liangan, Wang, Xing, Guo, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299884/
https://www.ncbi.nlm.nih.gov/pubmed/34927282
http://dx.doi.org/10.1002/ddr.21905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299884/
https://www.ncbi.nlm.nih.gov/pubmed/34927282
http://dx.doi.org/10.1002/ddr.21905

Ejemplares similares